EUVIMEDEUVIMED entdecken
Open Access

Cross‐Species Transcriptomic and Network Analysis of Human and Canine Diffuse Large B‐Cell Lymphoma Identifies a Conserved Replication– DNA Damage Module for Drug Repurposing

Soroush Akbari-Ardabili iD, Safiyeh Aghazadeh iD

Veterinary and Comparative Oncology · 2026-09 · 24 (3) · 578-592

DOI: 10.1111/vco.70079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 20.05.2026. Verfasst von Soroush Akbari-Ardabili und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Dog Diseases, Drug Repositioning, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rational, mechanism‐based drug selection for canine diffuse large B‐cell lymphoma (DLBCL) remains limited, despite extensive molecular work in human DLBCL. We asked whether human and canine DLBCL share a conserved transcriptional network that could anchor therapeutic hypotheses for dogs. Using public human and canine DLBCL transcriptomes, we derived a 409‐gene cross‐species module defined by concordant tumour–normal dysregulation and projected it onto pathway and protein–protein interaction (PPI) networks. The module was dominated by DNA replication, cell‐cycle checkpoint and DNA damage–response programmes and contained a compact PPI core centred on TOP2A and PARP1. Querying the Connectivity Map/LINCS library with the human component of the module highlighted anthracycline‐like topoisomerase II poisons (valrubicin, etoposide, amsacrine) and the PARP inhibitor rucaparib among the ~0.2% most negative connectivity scores, while directly targeting TOP2A and/or PARP1. A simple up–down module score strongly separated tumour from normal lymph nodes in both species and was associated with outcome: higher scores predicted longer progression‐free survival in CHOP‐treated dogs and better overall survival in an independent human cohort, with a similar but underpowered trend in TCGA‐DLBC. Finally, extracellular‐vesicle microRNA (EV‐miRNA) profiling in human DLBCL showed that differentially expressed EV‐miRNAs, including let‐7 family members, miR‐21‐5p, miR‐124‐3p and miR‐205‐5p, converge on the same TOP2A/PARP1‐centred core. These cross‐species, multi‐layer data support topoisomerase II poisons and PARP inhibition as coherent, network‐anchored candidate therapies for canine DLBCL, with module scores and EV‐miRNAs as candidate biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseDog DiseasesDrug RepositioningTranscriptomeAnimalsDogsHumansDNA DamageSpecies SpecificityGene Expression Regulation, NeoplasticDNA Topoisomerases, Type II

Stichwörter der Autor:innen

diffuse large B‐cell lymphomadogsmicroRNAsprotein interaction mappingsystems biologytranscriptome

Substanzen

DNA Topoisomerases, Type II

Autor:innen und Institutionen

  • Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.

ORCID-Profile: Soroush Akbari-Ardabili, Safiyeh Aghazadeh

Zitieren

APA

Akbari-Ardabili, S., & Aghazadeh, S. (2026). Cross‐Species Transcriptomic and Network Analysis of Human and Canine Diffuse Large B‐Cell Lymphoma Identifies a Conserved Replication– DNA Damage Module for Drug Repurposing. Veterinary and Comparative Oncology, 24(3), 578-592. https://doi.org/10.1111/vco.70079

Vancouver

Akbari-Ardabili S, Aghazadeh S. Cross‐Species Transcriptomic and Network Analysis of Human and Canine Diffuse Large B‐Cell Lymphoma Identifies a Conserved Replication– DNA Damage Module for Drug Repurposing. Veterinary and Comparative Oncology. 2026;24(3):578-592. doi:10.1111/vco.70079

BibTeX
@article{AkbariArdabili2026,
  author = {Akbari-Ardabili, Soroush and Aghazadeh, Safiyeh},
  title = {Cross‐Species Transcriptomic and Network Analysis of Human and Canine Diffuse Large B‐Cell Lymphoma Identifies a Conserved Replication– DNA Damage Module for Drug Repurposing},
  journal = {Veterinary and Comparative Oncology},
  year = {2026},
  volume = {24},
  number = {3},
  pages = {578--592},
  doi = {10.1111/vco.70079}
}
Kostenlos starten →